Inflammatory and prothrombotic biomarkers in patients with rheumatoid arthritis: effects of tumor necrosis factor-alpha blockade

Journal of Autoimmunity
Francesca IngegnoliMassimo Cugno

Abstract

Increased cardiovascular (CV) risk is a rheumatoid arthritis (RA) hallmark and it has been mainly related to chronic systemic inflammation. Since inflammation is linked to coagulation perturbation, both may play a role in increasing CV risk. Treatment with tumor necrosis factor (TNF)-alpha blocking agents is effective in RA and reduces local and systemic inflammation but there is little information on its effect on coagulation. We therefore investigated inflammation and coagulation plasma biomarkers before and after infliximab treatment in RA patients. We studied 20 patients with active RA and 40 healthy controls. Patients were treated with: a stable dose of methotrexate (10mg/week), and infliximab (3mg/kg) at weeks 0, 2, 6 and 14. At baseline and week 14, we determined: disease activity score (DAS-28), visual analogue scale pain, erythrocyte sedimentation rate (ESR), and plasma levels of C-reactive protein (CRP), TNF-alpha, interleukin (IL)-6, prothrombin fragment 1+2 (F1+2) and D-dimer. The same inflammation and coagulation parameters were evaluated 1h after infliximab infusion in 10 patients. At baseline, ESR, CRP, TNF-alpha, IL-6, F1+2 and D-dimer levels were significantly higher in RA patients than in controls (P=0.0001). ...Continue Reading

References

Jun 7, 1990·The New England Journal of Medicine·T van der PollJ W ten Cate
Feb 11, 1999·The New England Journal of Medicine·C Gabay, I Kushner
Oct 2, 2002·Arthritis and Rheumatism·Nathalie Busso, John A Hamilton

❮ Previous
Next ❯

Citations

Jul 26, 2011·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Jakub KwiecińskiTao Jin
Nov 1, 2011·Seminars in Immunopathology·Dimitrios Davalos, Katerina Akassoglou
Jan 13, 2010·Rheumatology International·Armen Yuri GasparyanGeorge D Kitas
Apr 15, 2010·Rheumatology International·Armen Yuri GasparyanGeorge D Kitas
Jun 25, 2009·Clinical Reviews in Allergy & Immunology·Torsten Matthias, Yehuda Shoenfeld
May 18, 2010·Lancet·Ioannis E Koutroubakis, Amado Salvador Pena
Nov 14, 2012·Nature Reviews. Rheumatology·Berthold Hoppe, Thomas Dörner
Aug 4, 2009·American Journal of Physiology. Lung Cellular and Molecular Physiology·Valeria M BorgesWilliam J Janssen
Mar 7, 2009·Arthritis Research & Therapy·Ravi C DwivediHani S El-Gabalawy
Dec 15, 2010·Hämostaseologie·S LipinskiP Rosenstiel
May 8, 2014·World Journal of Gastroenterology : WJG·Fernando MagroDália Fernandes
Nov 28, 2013·American Journal of Clinical Dermatology·Shannon FameniniJashin J Wu
Jan 17, 2014·Annals of the Rheumatic Diseases·I A M van den OeverM T Nurmohamed
Nov 4, 2009·Autoimmunity·Massimo CugnoAngelo V Marzano
Nov 28, 2014·Clinical and Experimental Medicine·Nicola MaruottiFrancesco Paolo Cantatore
Apr 1, 2011·Arthritis Care & Research·Henry R Kramer, Jon T Giles
Nov 30, 2012·Arthritis·Juan Camilo Sarmiento-MonroyAdriana Rojas-Villarraga
Aug 1, 2014·Seminars in Arthritis and Rheumatism·Jilke BeinsbergerJudith M E M Cosemans
Dec 24, 2014·The American Journal of Medicine·Seoyoung C KimSebastian Schneeweiss
Jul 31, 2012·Nanomedicine : Nanotechnology, Biology, and Medicine·Alberto AstolfoFulvia Arfelli
Dec 15, 2012·Clinical Neurology and Neurosurgery·Martin BulikMarek Mechl
May 19, 2010·Expert Review of Clinical Immunology·Massimo CugnoAngelo V Marzano
May 22, 2016·Journal of Cutaneous Medicine and Surgery·Wayne P GulliverPatrick Fleming
Nov 25, 2017·Scandinavian Journal of Gastroenterology·Yu NishidaYasuhiro Fujiwara
Feb 18, 2014·The Journal of Rheumatology·Matteo Nicola Dario Di MinnoUNKNOWN CaRRDs Study Group
Sep 10, 2009·Clinical and Experimental Immunology·A V MarzanoM Cugno
Jul 7, 2010·The Korean journal of laboratory medicine·So Young KangWoo In Lee
Oct 20, 2010·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Catharina ErikssonKarl-Gösta Sundqvist
Mar 10, 2020·Modern Rheumatology·Shoko TsujiYoshitaka Morita
Sep 11, 2014·Journal of Ophthalmology·Hsin-Yi ChenWen-Chi Chen
Dec 18, 2012·Clinical Chemistry and Laboratory Medicine : CCLM·Qin QinAnmei Deng
Jul 28, 2016·Terapevticheskiĭ arkhiv·T V PopkovaE L Nasonov
Jul 10, 2019·Frontiers in Immunology·Massimo CugnoAngelo Valerio Marzano
Aug 14, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Katsunori YoshidaM Eric Gershwin
May 4, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xiufen ZhengWeiping Min

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.